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Renin processing and secretion in adrenal and retina of transgenic
(mREN-2)27 rats. Two extrarenal tissue sources of renin were studied
using quantitative assays and immunocytochemical methods during 12
hours following binephrectomy (BNx) in anesthetized hypertensive ho-
mozygous Ren-2 transgenic (TG) rats maintained off hypotensive drugs
for three weeks. Compared to normal rats, circulating active renin was
depressed 50% in conscious TG rats and prorenin was 5- to 10-fold higher.
Post-BNx, arterial active and prorenin increased progressively to 10-fold,
at which time adrenal venous outputs were 0.1 and 20 mGU/min,
respectively. The ratio of active to prorenin (3.1 0.6%) remained
unchanged with increasing plasma levels. Thus, either intrinsic enzyme
activity of the transgenic prorenin contributed a constant proportion to the
measured active renin, or processing to mature renin was coupled to
prorenin synthesis and secretion in extrarenal tissues. In the TG rat eye,
renin protein labeling was localized throughout retinal MUller cells with
prosequence more obvious posteriorly, consistent with directional process-
ing. Immunogold studies are in progress. In adrenal following BNx,
labeling for renin and prosequence increased uniformaly in all zones of the
cortex and in scattered medullary chromaffin cells. In cortex, both renin
and prosequence were strongly located in intramitochondrial dense bod-
ies. In chromaffin cells, renin labeling was present in both cytoplasmic
vesicles and electron-dense granules, while prosequence was predomi-
nantly in cytoplasmic vesicles, consistent with processing of prorenin prior
to storage in chromaffin granules.
The major sites of extrarenal renin expression and possible
secretion in humans are adrenal gland and reproductive tract [1].
We have also recently localized renin to the retinal macroglia
Muller cell and presented morphological evidence consistent with
secretion into retinal capillaries [2]. But to date secretion of
extrarenal renin into blood in vivo has been convincingly shown
for only ovary, uterus and salivary gland in selected species [3, 4].
Compared with kidneys the renin content of adrenal glands and
eyes is low (ratio of 10:6:1 in the rat) [2] requiring immunocyto-
chemical and arterio-venous secretion studies to be conducted at
their detection limits. However, the transgenic (TG) REN-2 rat
which displays severe hypertension associated with amplified
extrarenal expression of a mouse renin transgene (Ren-2) together
with abundant secretion of its proform [5, 6] presents an oppor-
tunity to explore more precisely the physiology of tissue renin
synthesis, processing and secretion.
In order to study extrarenal renin production, binephrectomy
(BNx) is usually performed to eliminate any renal renin but this
procedure enhances adrenal gland renin content in both TG and
normal rats [7, 8] although to date actual secretion has not been
demonstrated. Importantly, following adrenalectomy (ADRx) in
BNx TG rats, continuing high levels of both active and prorenin
persist in the circulation [9] indicating other secretory sources.
In the present work we localize renin and prorenin immunocy-
tochemically in adrenal and retina of TG rats and quantitate the
adrenal secretion of each during 12 hours following BNx. These
experiments form part of an objective to characterize the process-
ing and Secretion of renin from all tissues of TG and normal rats
to further elucidate the biology of tissue renin. Whether the
REN-2 TG hypertensive rat represents an amplified but otherwise
qualitatively valid model of the normal state is a contentious issue
addressed in this continuing work.
Methods
Two hundred to 250 g female homozygous REN-2 TG rats
(Max-Deibruck-Centrum, Berlin-Buch, Germany) were studied
three weeks after removing maintenance angiotensin converting
enzyme inhibitor (ACEI, lisinopril 10 mg/mI) from the drinking
water. Systolic blood pressure (tail cuff) of conscious animals was
measured before withdrawing ACEI and again three weeks later
just prior to experimentation. A tail vein blood sample (400 1u1
into 5 U of heparin) was collected at this time. Blood was handled
as described below.
Operative procedures and experimental protocols
Rats were anesthetized with pentobarbitone (Nembutal 6 mg/
100 g body wt i.p.) prior to surgical procedures and maintained
deeply sedated thereafter. The trachea and carotid artery were
cannulated and the kidneys removed rapidly through flank inci-
sions. The flank incisions were closed and arterial renin levels
were followed from 30 minutes to 12 hours post-BNx. At seven to
eight hours the left flank was reopened and the left genital vein
was ligated and the cut end of the left renal vein was cannulated
with PE 50 tubing. The animal was then heparinized (80 U/100 g
i.v. initially and 20 U 2 hourly), the renal vein was ligated at its
junction with the vena cava and the adrenal venous blood flowing
from the cannula was recirculated into the jugular vein via a short
loop. This preparation has been deployed for the collection of
adrenal venous blood [10] and allows the measurement of blood
flow by air bubble transit time.
A-V plasma collections and renin assay
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Carotid arterial and adrenal venous blood (each 200 .il) were
collected simultaneously from the heparinized animal at intervals
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to 12 hours following BNx, Blood was replaced by volume with
isotonic saline. An aliquot (100 x1) of each blood sample was
immediately added to a cocktail of protease inhibitors on ice
(EDTA, N-ethyl maleimide, benzamidine) [11] and both aliquots
were then centrifuged cold. The plasmas were separated and
stored at —30°C prior to assay of active and total renin. The
proteases inhibitors were added to prevent spontaneous activation
of prorenin and these aliquots were used for active renin assay.
Total renin was assayed after trypsin activation of prorenin using
aliquots without inhibitors. The optimum concentration, time and
temperature conditions for trypsin activation were established to
be 2 mg/ml for 10 minutes at 4°C. Enzymatic renin activity was
then assayed after incubation (30 mm, 37°C, pH 7.4) by RIA of
generated angiotensin using 24 hours BNx rat plasma as the
substrate in the presence of further protease inhibitors and
expressed in Goldblatt units (GU) relative to the international
hog renin standard as previously described [11]. Prorenin was
derived as total minus active. Angiotensinogen (aogen) was
measured after incubation of plasma with unpurified mouse
salivary gland renin. Conditions for maximum generation and
survival of angiotensin I were established as previously stated [11].
Statistical testing
One-way ANOVA followed by a Newman-Keuls test and paired
t-tests were applied and justified as indicated in the text.
Tissue fixation
Adrenal glands from three female, 12-hour post-BNx TG rats
(see above) were immersed in Bouin's fluid for three hours for
immunohistochemistry. Five male transgenic REN-2 rats (200 to
250 g) that had received ACE! since weaning were anesthetized
with Nembutal (6 mg/i 00 g body wt i.p.) and prepared for vascular
perfusion as previously described [12]. The abdominal aorta was
cannulated and vascular perfusion was commenced at 200 mm Hg
using either Bouin's fixative (for immunohistochemistry, N = 3)
or 4% paraformaldehdye with 0.1% glutaraldehyde in 0.1 M
phosphate buffer at pH 7.4 (for immunogold, N = 2), and the
inferior vena cava adjacent to the renal vein was severed. After
five minutes of vascular perfusion (250 nil of fixative), adrenal
glands, eyes and kidneys were removed and post-fixed for two
hours in the same fixative. For immunohistochemistry, tissues
were dehydrated, routinely processed and embedded in paraffin.
For immunogold, tissues were rapidly dehydrated in graded
alcohols and embedded in London White resin (Bio-Rad, Cam-
bridge, Massachusetts, USA). One micrometer sections were
stained with methylene blue, the block was further trimmed and
ultrathin sections (70 nm) were cut with diamond knives and
placed on 0.5% Formar-coated nickel grids (EF Fullam, Inc.,
Schenetady, New York, USA).
Immunohistochemistiy
Three micrometer sections of tissues were incubated for 20
minutes with normal goat serum (NGS) diluted 1:10 with 0.1 M
phosphate buffered saline (PBS) at pH 7.4. The sections were
incubated for 18 hours at 4°C with either 1:20 to 1:200 polyclonal
anti-mouse renin protein antiserum [12], 1:20 to 1:200 polyclonal
anti-rat renin fusion protein antiserum [131, 1:20 to 1:400 poly-
clonal mouse prosequence antiserum [12] or 1:10 NGS. All
antisera were diluted in PBS. Antibody binding was visualized by
an avidin-biotin peroxidase technique using diaminobenzidine as
the chromagen. The sections were stained briefly in Mayer's
hematoxylin and differentiated in Scott's tap water, dehydrated,
cleared and mounted.
Immunogold
Methods for immunogold have been previously described [12].
Briefly, ultrathin sections of adrenal gland cortex and medulla
were incubated for 10 minutes with 1:10 NGS. The sections were
then incubated for 18 hours at 4°C with either 1:10 to 1:20
polyclonal anti-mouse renin antiserum, 1:10 polyclonal anti-rat
renin antiserum, 1:20 to 1:50 polyclonal anti-mouse prosequence
antiserum or 1:10 NGS. All antisera were diluted in PBS. After
thorough rinsing in PBS (3 X 20 mm), sections were incubated
with goat anti-rabbit IgG-coated particles (15 nm, Biocell, Cardiff,
UK) diluted 1:25 with PBS for one hour at room temperature.
Sections were rinsed with PBS (3 X 20 mm) and distilled water (2
x 5 mm). The sections were stained with uranyl acetate (5 mm)
and lead citrate (5 mm) and examined in a Phillips CM12 electron
microscope.
Antisera specificities
The renin protein and prosequence antisera specifically label
juxtaglomerular cells of the kidney, the adrenal cortex, Muller
cells of the eye and granulated convoluted tubules of the mouse
submandibular gland [2, 12, 13]. The mouse prosequence anti-
serum is raised against a synthetic oligopeptide epitope in the
prosequence [12] and reacts only with the proform. The mouse
and rat renin protein antisera display cross reactivity.
Results
Conscious blood pressure of TG rats
Mean tail artery systolic pressure of 200 to 250 g TG female rats
raised from weaning on ACE! in drinking water was 118 3.2mm
Hg (N = 8). Three weeks off ACEI, mean pressure was 141 5.0
mm Hg (P < 0.001, N = 7, unpaired t test).
Effect of BNx on arterial renin in TG rats
Immediately following BNx the plasma levels were not different
from conscious pre-operation tail vein levels indicating that
neither anesthesia nor BNx caused acute release of renin. Within
30 minutes of BNx, active renin and prorenin were significantly
elevated in arterial plasma and increased progressively to reach
10-fold control at 12 hours post-BNx (Fig. 1). Despite the
progressive increase in both renin forms the concentration ratio
did not change from the conscious value of 3.1 0.6. Figure 1 also
shows that following BNx, aogen increased progressively in a
manner similar to normal rats [14] despite the fact that active
renin increased 10-fold.
Renin release from the adrenal gland of TG rats
Figure 1 shows that at 8, 10 and 12 hours post-BNx, the three
times at which it was measured, a positive veno-arterial (V-A)
difference for both active renin and prorenin was present across
the left adrenal gland. The left adrenal venous outflow rate
averaged 130.4 4,8 il/min (N = 6) at 8 to 12 hours post-BNx
and calculated secretion rates from two adrenals were 0.1 and 20
mGU/min for active and prorenin, respectively, at 12 hours.
Aogen did not display a V-A difference.
*It
*
*
3-
2-0
E
C
C
a, 1-
0-
*
4 6 8 10 12
Time, hours
200 j B
A
t0
*
.2 *
=
8a
0 2
1'
BNx
to **
.2 * *
* * T
0246
BNx Time, hours
309 2.63 2.64 4.67 5.76 5.42 3.53
*0.3 —0.5 *0.9
0
0
=
I
* It
*It *
10 12
0
active
proreriifl
2400-
2000.
1600
1200
=
to
=o 8000
0)
400
0•
*
* * *
* * *
* *
0 2t
BNX
4 6 8 10 12
lime, hours
Rong et al: Extrarenal renin in Ren-2 transgenic rats 1585
Immunocytochemistiy
In the adrenal glands of TG rats, intense and specific labeling
for anti-rat renin protein (1:100), anti-mouse renin protein (1:100,
Fig. 2A) was seen in cells of the zona glomerulosa (ZG), zona
fasciculata (ZF) and zona reticularis (ZR) and in some medullary
cells. In the cortex, labeling appeared granular and was strongest
around nuclei, while in medullaty cells labeling was evenly
distributed throughout the cytoplasm. A similar pattern of label-
ing was seen for anti-mouse prorenin (1:200), but labeling was
more intense (Fig. 2B). Following 12 hours of BNx in TG rats
labeling for anti-mouse (1:200) and anti-rat (1:200) renin protein
and anti-mouse prorenin (1:400) was more intense in the adrenal
cortex and the scattered medullary cells (Fig. 2 C, D). In the retina
of TG rats, specific labeling for anti-mouse renin protein (1:200)
was seen only in macroglial Muller cells (not shown). Labeling was
more intense than in Muller cells of Sprague-Dawley rat eyes,
particularly in the endfeet which made numerous contacts with
retinal blood vessels. Intense labeling for anti-mouse prorenin
(1:200) was observed between photoreceptor cell nuclei, corre-
sponding to Muller cell processes.
Immunogold
In TG rat adrenal cortex, cortical cells contained numerous
mitochondria (Fig. 2E), with intense labeling for anti-mouse
(1:20) and anti-rat (1:20) renin protein and anti-mouse prorenin
(1:20) in intramitochondrial dense bodies of mitochondria in ZG,
ZF and ZR (Fig. 2F). Some labeling was seen over the remaining
mitochondrial matrix. In the adrenal medulla, some cells con-
tained chromaffin granules (Fig. 2G). In these cells the anti-rat
(1:20) and anti-mouse (1:20) renin protein antisera specifically
labeled cytoplasmic vesicles and occasional small electron-dense
granules distributed throughout the cytoplasm (Fig. 2H). Labeling
for anti-mouse prorenin (1:20) was mainly detected in cytoplasmic
vesicles (Fig. 21).
Discussion
Fig. 1. Arterial (black) and venous (hatched) plasma active renin (A),
prorenin (B) and angiotensinogen (C) before (conscious) and to 12 hours
following BNx in 5 frmale Ren-2 TG rats. Values are plotted as mean
SEM. The ratios of active to prorenin are shown with respect to time. The
increase in arterial values (* ** P < 0.001) was tested by one-way ANOVA
compared with the zero time post-BNx value. The veno-arterial difference
was tested by paired t-test (# P < 0.05).
Increases in circulating active and prorenin in 24 hour BNx TG
Ren-2 rats have been reported recently together with evidence
that tissue sources in addition to adrenal are involved, particularly
for active renin [7, 8]. The present experiments show the time
course of the increases and allow the conclusion that by 12 hour
post-BNx, the two adrenals are secreting active renin at rates
equivalent to the kidneys of normal pentobarbital anesthetized
rats. Thus at 12 hours post-BNx the arterial level of active renin (2
mGU/ml) is about sixfold higher than for normal Sprague-Dawley
rats (0.32 mGUIml) [11], and for prorenin 200-fold higher [15].
The rate of adrenal renin secretion (0.1 mGU/min) is comparable
to that found for normal rat kidneys (deduced from a clearance
rate of 2.9 ml plasma/kg/mm) [16]. It must be noted, however, that
the assayed active renin is probably wholly transgenic mouse renin
and further, that this in vitro activity could be due exclusively to
the prorenin content if it possesses 3 to 4% of its potential enzyme
activity, as has been reported for recombinant human renin [17].
The fact that the ratio of active to prorenin in arterial plasma
remained statistically unchanged at 2.6 to 5.7% despite 10-fold
increases in each, indicates either that Ren-2 mouse prorenin
possesses a constant low enzymatic activity in plasma, or that
processing to mature active Ren-2 renin and its subsequent
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Fig. 2. Three micrometer paraffin sections of adrenal glands from TG rats labeled with antisera to renin protein and prorenin. Mayer's hematoxylin
counterstain. Abbreviations are: ZG, zona glomerulosa; ZF, zona fasiculata; ZR, zona reticularis, M, medulla. (Magnification x264). A. Labeling for
anti-mouse renin protein (1:100, arrows) is intense and granular in perinuclear regions of ZG, ZF and ZR cells. Labeling is seen in some medullary cells
(arrow) and is evenly distributed throughout the cytoplasm. B. Labeling for anti-mouse prorenin (1:200, arrows) in ZG, ZF, ZR and some medullaiy
cells is more intense than for renin protein. C. Adrenal medulla following 12 hour BNx. Labeling for anti-mouse renin protein (1:200, arrows) appears
more intense and granular than in controls. Labeling is seen throughout the cell cytoplasm. D. Adrenal medulla following 12 hour BNx. Labeling for
anti-mouse prorenin (1:200, arrows) appears more intense than in controls. Transmission electron micrographs of transgenic rat adrenal gland. Uranyl
acetate and lead citrate counterstain. E. Zona reticularis. Numerous mitochondria (arrows) are distributed throughout the cell cytoplasm.
(Magnification x10,000). F. Higher magnification of zona reticularis cell shown in Fig. 2E. Labeling for anti-mouse renin protein (1:20) is intense in
intramitochondrial dense bodies (arrow). Some labeling is also seen over the mitochondrial matrix (asterisk). (Magnification X70,000). G. Medullary
chromaffin cells. Numerous small electron-dense granules (arrows) are found throughout the cytoplasm. (Magnification X7600). H. Higher
magnification of a medullary chromaffin cell shown in Fig. 2G. Occasional electron-dense granules are labeled for anti-mouse renin protein (1:20,
arrow). (Magnification x56,000). I. Higher magnification of a medullary chromaffin cell shown in Fig. 20. Cytoplasmic vesicles labeled for prorenin
(1:20, arrow) are found in the cell cytoplasm. Most large electron-dense granules are not labeled for prorenin (asterisk). (Magnification X 123,000).
secretion is tightly coupled to synthesis and secretion of prorenin
in the tissues of origin.
In the normal rat, mouse and human eye, renin but not
prosequence labeling can be seen in macroglial Muller cells, which
span almost the entire width of the retina and are closely
associated with retinal blood vessels at their anterior surface [2].
In TG rats, prorenin labeling was clearly seen and was confined to
the posterior part of the MUller cell, while labeling for renin
extended throughout the cell cytoplasm, consistent with renin
being processed in the direction of retinal blood vessels. Immu-
nogold studies are in progress to determine the precise processing
and secretory pathways in these cells. In the adrenal the localiza-
tion of renin and prorenin labeling to intramitochondrial dense
bodies in all cortical adrenal zones is consistent with recent
publications [18, 191, and together with the presence of angioten-
sin type 1 receptors on the membranes of mitochondria [19]
indicate a possible role for a renin-angiotensin system as an
intacrine system in steriodogenesis. In the normal and TG rat,
labeling for renin and prorenin were also found in some cells of
the adrenal medulla. Immunogold studies revealed that the active
renin is located in chromaffin granules, while prorenin is confined
to cytoplasmic vesicles. The processing enzymes involved in the
activation of renin within medullary cells, verification of the cell
type, and the contributions of chromaffin granules and cortical
mitochondrial renin to post-BNx plasma levels and the normal
functions of adrenal renin all remain to be determined.
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